<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Farmasian tiedekunta (pro gradu)</title>
<link href="http://hdl.handle.net/123456789/8" rel="alternate"/>
<subtitle/>
<id>http://hdl.handle.net/123456789/8</id>
<updated>2026-05-31T19:35:45Z</updated>
<dc:date>2026-05-31T19:35:45Z</dc:date>
<entry>
<title>Impact of cellular stressors on the localization and expression dynamics of mesencephalic astrocyte-derived neurotrophic factor</title>
<link href="http://hdl.handle.net/123456789/54452" rel="alternate"/>
<author>
<name/>
</author>
<id>http://hdl.handle.net/123456789/54452</id>
<updated>2024-09-19T22:45:30Z</updated>
<published>2024-09-19T00:00:00Z</published>
<summary type="text">Impact of cellular stressors on the localization and expression dynamics of mesencephalic astrocyte-derived neurotrophic factor
</summary>
<dc:date>2024-09-19T00:00:00Z</dc:date>
</entry>
<entry>
<title>Validation of thermostable vaccines: model and proof of concept</title>
<link href="http://hdl.handle.net/123456789/54394" rel="alternate"/>
<author>
<name/>
</author>
<id>http://hdl.handle.net/123456789/54394</id>
<updated>2024-09-18T22:45:24Z</updated>
<published>2024-09-18T00:00:00Z</published>
<summary type="text">Validation of thermostable vaccines: model and proof of concept
</summary>
<dc:date>2024-09-18T00:00:00Z</dc:date>
</entry>
<entry>
<title>Synthesis of Novel N-Sulphamoylpyrrole-2-carboxylate Derivatives as Potential Metallo-β-lactamase Inhibitors</title>
<link href="http://hdl.handle.net/123456789/54393" rel="alternate"/>
<author>
<name/>
</author>
<id>http://hdl.handle.net/123456789/54393</id>
<updated>2024-09-18T22:45:25Z</updated>
<published>2024-09-18T00:00:00Z</published>
<summary type="text">Synthesis of Novel N-Sulphamoylpyrrole-2-carboxylate Derivatives as Potential Metallo-β-lactamase Inhibitors
</summary>
<dc:date>2024-09-18T00:00:00Z</dc:date>
</entry>
<entry>
<title>Alzheimerin taudin riskiä lisäävät lääkeaineet ja niiden hallittu lopettaminen (deprescribing) – valmisteyhteenvedoista, pakkausselosteista ja hoitosuosituksista saatavilla oleva informaatio</title>
<link href="http://hdl.handle.net/123456789/54237" rel="alternate"/>
<author>
<name/>
</author>
<id>http://hdl.handle.net/123456789/54237</id>
<updated>2024-09-12T22:45:22Z</updated>
<published>2024-09-12T00:00:00Z</published>
<summary type="text">Alzheimerin taudin riskiä lisäävät lääkeaineet ja niiden hallittu lopettaminen (deprescribing) – valmisteyhteenvedoista, pakkausselosteista ja hoitosuosituksista saatavilla oleva informaatio
</summary>
<dc:date>2024-09-12T00:00:00Z</dc:date>
</entry>
</feed>
